Mesa Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Mesa Laboratories
MLAB Stock  USD 78.50  0.10  0.13%   
Mesa Laboratories' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mesa Laboratories' valuation are provided below:
Gross Profit
152.4 M
Profit Margin
(0.01)
Market Capitalization
434.1 M
Enterprise Value Revenue
2.4941
Revenue
245.3 M
We have found one hundred twenty available fundamental ratios for Mesa Laboratories, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Mesa Laboratories last-minute market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 525.9 M. The current year's Enterprise Value is expected to grow to about 564.5 M

Mesa Laboratories Total Revenue

253.03 Million

Check Mesa Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mesa Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 12.5 M, Total Revenue of 253 M or Gross Profit of 158.4 M, as well as many indicators such as Price To Sales Ratio of 2.92, Dividend Yield of 0.0051 or PTB Ratio of 2.38. Mesa financial statements analysis is a perfect complement when working with Mesa Laboratories Valuation or Volatility modules.
  
Build AI portfolio with Mesa Stock
Check out the analysis of Mesa Laboratories Correlation against competitors.
For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.

Mesa Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets455 M433.3 M294.5 M
Slightly volatile
Other Current Liabilities29.7 M28.3 M12 M
Slightly volatile
Total Current Liabilities172.2 M164 M40.4 M
Slightly volatile
Total Stockholder Equity167.8 M159.8 M157.2 M
Slightly volatile
Cash17.7 M27.3 M34.2 M
Slightly volatile
Non Currrent Assets Other17.6 M18.3 M65.1 M
Very volatile
Cash And Short Term Investments17.8 M27.3 M34.2 M
Slightly volatile
Net Receivables44.1 M42 M21.7 M
Slightly volatile
Common Stock Shares Outstanding4.3 M5.4 M4.3 M
Slightly volatile
Liabilities And Stockholders Equity455 M433.3 M294.5 M
Slightly volatile
Inventory26.6 M25.4 M15.2 M
Slightly volatile
Total Liabilities287.2 M273.5 M137.3 M
Slightly volatile
Total Current Assets107.8 M102.7 M76.5 M
Slightly volatile
Non Current Liabilities Total115 M109.6 M96.9 M
Slightly volatile
Other Current Assets5.3 M8 M10.3 M
Slightly volatile
Short and Long Term Debt Total190.5 M181.5 M94.9 M
Slightly volatile
Accounts Payable6 M5.7 M3.5 M
Slightly volatile
Short Term Debt109.8 M104.6 M17.9 M
Slightly volatile
Intangible Assets101.7 M96.9 M65.7 M
Slightly volatile
Common Stock Total Equity401 M381.9 M151.6 M
Slightly volatile
Common Stock376.5 M358.5 M148.2 M
Slightly volatile
Property Plant Equipment34 M32.4 M19.8 M
Slightly volatile
Good Will190.8 M181.8 M114.2 M
Slightly volatile
Current Deferred Revenue8.2 M14.7 M6.8 M
Slightly volatile
Retained Earnings Total Equity68.3 M85.3 M63.9 M
Slightly volatile
Other Liabilities32.9 M41.4 M27.8 M
Slightly volatile
Long Term Debt Total221.3 M210.8 M92.5 M
Slightly volatile
Non Current Liabilities Other13.1 M12.5 M4.5 M
Slightly volatile
Short and Long Term Debt122 M116.2 M51.3 M
Slightly volatile
Net Invested Capital424.3 M337.8 M283.1 M
Slightly volatile
Deferred Long Term Asset Charges101.6 K114.3 K124.6 K
Slightly volatile
Capital Stock292.8 M358.5 M154.7 M
Slightly volatile
Capital Lease Obligations2.6 M3.5 M1.7 M
Slightly volatile

Mesa Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue253 M241 M122.1 M
Slightly volatile
Gross Profit158.4 M150.9 M74.1 M
Slightly volatile
Other Operating Expenses235.9 M224.6 M127.8 M
Slightly volatile
Cost Of Revenue94.6 M90.1 M48 M
Slightly volatile
Total Operating Expenses141.3 M134.5 M79.8 M
Slightly volatile
Depreciation And Amortization25.8 M24.5 M13.8 M
Slightly volatile
Research Development20.5 M19.5 M8.6 M
Slightly volatile
Selling General Administrative77 M73.3 M36.8 M
Slightly volatile
Selling And Marketing Expenses39.6 M41.7 M134.4 M
Slightly volatile
Non Recurring77.8 K81.9 K5.8 M
Slightly volatile
Reconciled Depreciation22.6 M24.5 M15.8 M
Slightly volatile
Interest Income91.5 K96.3 K638.5 K
Slightly volatile

Mesa Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow17.8 M28.2 M32.7 M
Slightly volatile
Depreciation25.8 M24.5 M13.8 M
Slightly volatile
Total Cash From Operating Activities49.1 M46.8 M24.9 M
Slightly volatile
End Period Cash Flow18.3 M27.3 M34.3 M
Slightly volatile
Stock Based Compensation21.6 M13.1 M6.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.922.67334.8966
Pretty Stable
Dividend Yield0.00510.00540.0068
Slightly volatile
PTB Ratio2.384.03063.8674
Very volatile
Days Sales Outstanding84.3463.570364.7644
Slightly volatile
Book Value Per Share30.9129.4434.0877
Slightly volatile
Operating Cash Flow Per Share9.058.62185.4834
Slightly volatile
Average Payables192.9 K131.1 K129.3 K
Pretty Stable
Stock Based Compensation To Revenue0.05180.05450.035
Slightly volatile
Capex To Depreciation0.170.18340.5304
Slightly volatile
PB Ratio2.384.03063.8674
Very volatile
EV To Sales2.843.3135.1337
Pretty Stable
Inventory Turnover1.833.55253.1631
Very volatile
Days Of Inventory On Hand97.61103119
Slightly volatile
Payables Turnover20.6815.679115.3338
Pretty Stable
Sales General And Administrative To Revenue0.20.30430.2709
Slightly volatile
Average Inventory1.7 M2.1 M2.3 M
Pretty Stable
Research And Ddevelopement To Revenue0.0850.0810.0598
Slightly volatile
Capex To Revenue0.01770.01870.0391
Slightly volatile
Cash Per Share2.885.03247.1437
Slightly volatile
POCF Ratio14.5613.762724.5439
Pretty Stable
Capex To Operating Cash Flow0.09130.09610.2707
Slightly volatile
Days Payables Outstanding17.9323.279326.2084
Very volatile
EV To Operating Cash Flow14.6117.05626.4143
Pretty Stable
Intangibles To Total Assets0.680.6430.5918
Slightly volatile
Current Ratio0.590.62632.9464
Pretty Stable
Receivables Turnover3.995.74175.7354
Slightly volatile
Shareholders Equity Per Share30.9129.4434.0877
Slightly volatile
Debt To Equity1.191.13540.5461
Slightly volatile
Capex Per Share0.420.82870.7741
Very volatile
Average Receivables2.5 M2.2 M2 M
Slightly volatile
Revenue Per Share46.6144.387226.6138
Slightly volatile
Interest Debt Per Share37.3935.610820.0061
Slightly volatile
Debt To Assets0.440.41880.2668
Slightly volatile
Graham Number12.1415.3526.3287
Pretty Stable
Short Term Coverage Ratios0.40.424.9844
Very volatile
Operating Cycle293166192
Very volatile
Price Book Value Ratio2.384.03063.8674
Very volatile
Days Of Payables Outstanding17.9323.279326.2084
Very volatile
Price To Operating Cash Flows Ratio14.5613.762724.5439
Pretty Stable
Company Equity Multiplier2.852.71131.8013
Slightly volatile
Long Term Debt To Capitalization0.220.32480.27
Slightly volatile
Total Debt To Capitalization0.560.53170.3159
Slightly volatile
Debt Equity Ratio1.191.13540.5461
Slightly volatile
Quick Ratio0.450.47162.2618
Very volatile
Dividend Paid And Capex Coverage Ratio7.915.87524.6921
Slightly volatile
Cash Ratio0.160.16661.209
Very volatile
Cash Conversion Cycle271143167
Very volatile
Operating Cash Flow Sales Ratio0.180.19420.207
Very volatile
Days Of Inventory Outstanding97.61103119
Slightly volatile
Days Of Sales Outstanding84.3463.570364.7644
Slightly volatile
Cash Flow Coverage Ratios0.250.25790.7087
Slightly volatile
Price To Book Ratio2.384.03063.8674
Very volatile
Capital Expenditure Coverage Ratio18.0310.404111.2725
Slightly volatile
Price Cash Flow Ratio14.5613.762724.5439
Pretty Stable
Debt Ratio0.440.41880.2668
Slightly volatile
Cash Flow To Debt Ratio0.250.25790.7087
Slightly volatile
Price Sales Ratio2.922.67334.8966
Pretty Stable
Asset Turnover0.740.55610.5412
Slightly volatile
Gross Profit Margin0.690.62610.6059
Slightly volatile
Price Fair Value2.384.03063.8674
Very volatile

Mesa Laboratories Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap525.9 M500.9 M517.3 M
Slightly volatile
Enterprise Value564.5 M537.6 M555 M
Slightly volatile

Mesa Fundamental Market Drivers

Forward Price Earnings35.2113
Cash And Short Term Investments27.3 M

Mesa Upcoming Events

5th of February 2024
Upcoming Quarterly Report
View
23rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
23rd of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

About Mesa Laboratories Financial Statements

Mesa Laboratories stakeholders use historical fundamental indicators, such as Mesa Laboratories' revenue or net income, to determine how well the company is positioned to perform in the future. Although Mesa Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mesa Laboratories' assets and liabilities are reflected in the revenues and expenses on Mesa Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mesa Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14.7 M8.2 M
Total Revenue241 M253 M
Cost Of Revenue90.1 M94.6 M
Stock Based Compensation To Revenue 0.05  0.05 
Sales General And Administrative To Revenue 0.30  0.20 
Research And Ddevelopement To Revenue 0.08  0.09 
Capex To Revenue 0.02  0.02 
Revenue Per Share 44.39  46.61 
Ebit Per Revenue 0.07  0.06 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C
When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:
How To Invest In Mesa
Details
Is Mesa Stock a good investment?
Details
What is Mesa Laboratories' Net Worth?
Details
Largest Life Sciences Tools & Services Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Mesa Laboratories Correlation against competitors.
For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.29)
Dividend Share
0.64
Earnings Share
(0.31)
Revenue Per Share
44.898
Quarterly Revenue Growth
0.05
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY